Soleil Securities recommends buying shares of Celgene (Nasdaq: CELG) ahead of ASCO.

Soleil analyst says, "Considering CELG is off 9.2 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE